Winthrop Partners - WNY’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.52M Buy
13,875
+56
+0.4% +$13.1K 1.74% 23
2026
Q1
$3.38M Buy
13,819
+536
+4% +$125K 1.8% 22
2025
Q4
$2.75M Buy
+13,283
New +$2.63M 1.48% 25
2019
Q3
$1.24M Sell
9,602
-317
-3% -$41.8K 0.84% 43
2019
Q2
$1.38M Buy
9,919
+350
+4% +$48.4K 1.04% 35
2019
Q1
$1.33M Sell
9,569
-3,035
-24% -$407K 1.04% 35
2018
Q4
$1.63M Sell
12,604
-450
-3% -$62.8K 1.52% 20
2018
Q3
$1.8M Sell
13,054
-2,057
-14% -$273K 1.46% 20
2018
Q2
$1.83M Sell
15,111
-1,145
-7% -$143K 1.53% 18
2018
Q1
$2.1M Hold
16,256
1.62% 17
2017
Q4
$2.18M Buy
+16,256
New +$2.26M 1.77% 18

Other funds holding JNJ

Winthrop Partners - WNY's JNJ Position: Q2 2026 in Review

Winthrop Partners - WNY increased its Johnson & Johnson (JNJ) stake by 0.41% in Q2 2026, buying an estimated $13.1K and bringing the position to 13,875 shares worth $3.52M. The position accounts for 1.74% of the portfolio, ranked #23.

Winthrop Partners - WNY first reported a position in JNJ in Q4 2017 and has held it in 11 quarters since. 2,987 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Winthrop Partners - WNY held 13,875 shares of Johnson & Johnson worth $3.52M as of Q2 2026.
  • Winthrop Partners - WNY bought 56 Johnson & Johnson shares in Q2 2026, an estimated $13.1K.
  • Johnson & Johnson made up 1.74% of Winthrop Partners - WNY's portfolio in Q2 2026, its #23 holding.
  • Winthrop Partners - WNY first reported a position in Johnson & Johnson in Q4 2017 and has held it in 11 quarters since.
  • 2,987 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Winthrop Partners - WNY's 13F filing for Q2 2026, filed 15 Jul 2026.